Notícias e Atividades da Opko Health

Opko Health é uma das ...

• Russell 3000;
• TOB Iconic 10,000.

Opko Health é uma empresa listada sob o símbolo OPK (US).

Opko Health possui 3 subsidiárias incluindo Bio-Reference Laboratories, ModeX Therapeutics e Opko Renal.

Eles estão dentro:

• Saúde50%
• Farmacêutica25%
• Outro25%

Veja o organograma con seus 43 executivos principais

Biografias mais buscadas da Opko Health

• Phillip Frost, Chairman of the Board & Chief Executive Officer
• Prem Lachman, Director
• Alice Lin-Tsing Yu, Director

Criar um alerta
para seguir os movimentos de executivos da Opko Health.

Opko Health possui 1.834 concorrentes concorrentes Pfizer (Estados Unidos), Sanofi (França) e Eli Lilly (Estados Unidos).

Popular M&A news in Farmacêutica

• Imbria Pharmaceuticals acaba de anunciar uma arrecadação de fundos de 58 milhões de dólares. (publicado em 10 de abril de 2025).
• Clario adquiriu NRx Pharmaceuticals (publicado em 18 de março de 2025).
• Knight Therapeutics has announced the acquisition of Paladin Labs  (publicado em 12 de março de 2025).

Outros contatos sugeridos na indústria do Farmacêutica

• Estelle Vester-Blokland - Senior Vice President, Medical and Head, International Markets da Bristol-Myers Squibb
• Kristin Berkinsky - Chief Human Resources Officer da Adare Pharmaceuticals
• Seth Harrison - Chairman and Director da Braeburn Pharmaceuticals

Saiba mais sobre a indústria do Farmacêutica

Últimos comunicados de imprensa de Opko Health

• OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program
• OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders
• Press Releases
• OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results
• OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference
• OPKO Health’s ModeX Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration with Merck
• OPKO Health to Participate in the Piper Sandler 36th Annual Healthcare Conference
• OPKO Health Reports Third Quarter 2024 Business Highlights and Financial Results
• ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program
• OPKO Health’s ModeX Therapeutics Appoints Dr. Giovanni Abbadessa as Chief Medical Officer as Pipeline Advances into Clinical Development
• View more press releases Close

Redes sociais sobre Opko Health

• Opko Health na Wikipedia, Google News e Yahoo Finance
• Opko Health na LinkedIn, Twitter e YouTube